The potential of combined immunotherapy and antiangiogenesis for the synergistic treatment of advanced NSCLC
Manegold C, Dingemans AC, Gray JE et al. J Thorac Oncol 2017; 12: 194–207. doi: 10.1016/j.jtho.2016.10.003
Please follow the link below to view this article in full on a third party website. Note that a subscription or payment may be required.